TECH vs TMO vs RGEN Stock Comparison

Bio-Techne, Thermo Fisher Scientific and Repligen Prices as of Nov 13, 2026 Peers: Industry group
TECH BIO-TECHNE Corp
$72.80 +0.4% 1M +19.8% 1Y
Market cap
$11.43B
P/E
66.4x
Revenue (TTM)
$1.23B
Div. yield
0.55%
Life Sciences Tools Healthcare
2 wins
RGEN Repligen Corp
$167.79 -5.8% 1M +11.4% 1Y
Market cap
$9.51B
P/E
–
Revenue (TTM)
$805.61M
Div. yield
–
Life Sciences Tools Healthcare
2 wins

Head to Head

12 decided of 12

Thermo Fisher Scientific leads on 8 of the 12 questions below (Thermo Fisher Scientific 8, Repligen 2, Bio-Techne 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionTECHTMORGENLeader
Larger companyMarket capitalisation $11.43B $259.44B $9.51B TMO
Cheaper on earningsLower P/E, profitable companies only 66.4x 36.6x -804.0x TMO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 33.4x 27.0x 86.0x TMO
Faster revenue growthRevenue growth, trailing twelve months +0.9% +8.3% +13.8% RGEN
More profitableNet margin, trailing twelve months 14.0% 14.9% -1.5% TMO
Better return on capitalReturn on invested capital 7.8% 8.0% 0.0% TMO
Less leveragedLower net debt / EBITDA -0.4x 3.1x -2.8x RGEN
Higher dividend yieldTrailing dividend yield 0.55% 0.26% — TECH
Better 1-year returnPrice return, last 12 months +19.8% +20.7% +11.4% TMO
Better 5-year returnAnnualised price return, 5 years -10.4%/yr +2.0%/yr -8.3%/yr TMO
Less volatileAnnualised volatility, 1 year 42.8% 30.7% 46.5% TMO
Higher overall scoreMean of the five percentile scores vs peers 68/100 60/100 58/100 TECH

Percentile Scorecard

TECHTMORGEN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisTECHTMORGEN
Valuation 62 #92 of 243 62 #94 of 243 56 #108 of 243
Growth 56 #102 of 228 41 #136 of 228 30 #161 of 228
Profitability 94 #15 of 222 82 #40 of 222 67 #75 of 222
Financial Health 79 #53 of 248 31 #172 of 248 80 #50 of 248
Shareholder Returns 47 #84 of 158 82 #29 of 158 57 #68 of 158
Overall 68 60 58
  • TECH ranked among 252 companies in Medical Devices and Diagnostics
  • TMO ranked among 252 companies in Medical Devices and Diagnostics
  • RGEN ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodTECHTMORGENSPY
1 month +0.4%+4.0%-5.8% -2.0%
3 months +0.6%+19.1%+0.6% -2.8%
6 months +68.1%+59.7%+63.1% +2.0%
Year to date +23.8%+20.8%+2.4% +10.6%
1 year +19.8%+20.7%+11.4% +12.2%
3 years +20.6%+52.5%+9.1% +68.1%
3 years, per year +6.5%+15.1%+2.9% +18.9%
5 years -42.3%+10.2%-35.1% +61.4%
5 years, per year -10.4%+2.0%-8.3% +10.1%
10 years +173.4%+362.9%+419.6% +248.5%
10 years, per year +10.6%+16.6%+17.9% +13.3%

Risk

MeasureTECHTMORGENSPY
Volatility, 1Y 42.8%30.7%46.5% 13.6%
Downside volatility, 1Y 43.2%29.2%47.4% 13.9%
Beta vs S&P 500, 1Y 0.630.711.21 1.00
Return / volatility, 1Y 0.460.670.25 0.90
Max drawdown, 5Y -66.5%-41.5%-64.7% -25.4%
From 52-week high -0.1%-3.0%-13.8% -3.2%
52-week high $72.84$721.63$194.57 $779.14
52-week low $43.30$438.34$102.87 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleTECHTMORGEN
P/E now vs peer median 66.4xmedian 26.5x 36.6xmedian 26.5x -804.0xmedian 26.5x
P/S now vs peer median 9.3xmedian 2.7x 5.5xmedian 2.7x 11.8xmedian 2.7x
EV/EBITDA now vs peer median 33.4xmedian 18.4x 25.5xmedian 18.4x 83.9xmedian 18.4x
P/FCF now vs peer median 37.1xmedian 25.4x 34.2xmedian 25.4x 89.1xmedian 25.4x
P/B now vs peer median 5.3xmedian 2.5x 4.7xmedian 2.5x 4.5xmedian 2.5x
PEG now vs peer median -6.27median 0.98 4.84median 0.98 28.28median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsTECHTMORGEN
Revenue $1.23B $47.35B $805.61M
Gross profit $807.58M $19.45B $430.67M
Operating income $240.84M $8.47B $18.24M
Net income $171.97M $7.09B -$11.80M
Free cash flow $308.20M $7.60B $106.72M
R&D $96.87M $1.40B $57.23M
EPS (diluted) $1.09 $19.06 $-0.21
Cash & equivalents $350.04M $5.46B $726.96M
Total debt $200.00M $41.37B $555.60M
Shares (diluted) 157.93M 371.00M 56.56M
Enterprise value $10.44B $236.08B $6.29B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricTECHTMORGEN
P/E 66.4x 36.6x -804.0x
P/FCF 37.1x 34.2x 89.1x
P/Operating cash flow 33.9x 27.8x 73.2x
P/S 9.3x 5.5x 11.8x
P/B 5.3x 4.7x 4.5x
P/Tangible book 6.1x 7.1x 5.3x
EV/EBITDA 33.4x 25.5x 83.9x
EV/EBIT 46.9x 34.8x 504.7x
EV/Revenue 9.2x 6.2x 11.4x
EV/FCF 36.6x 38.8x 86.3x
EV/Operating cash flow 33.4x 31.6x 70.9x
PEG (3Y EPS CAGR) -6.27 4.84 28.28

Growth

14 metrics
MetricTECHTMORGEN
Revenue growth (1Y) 0.9% 8.3% 13.8%
Revenue CAGR (3Y) 2.4% 2.9% 7.3%
Gross profit growth (1Y) 1.5% 7.8% 33.0%
Gross profit CAGR (3Y) 1.4% 4.0% 13.3%
Operating income growth (1Y) 119.1% 12.8% 2,185%
Operating income CAGR (3Y) -6.9% 7.2% -40.5%
Net income growth (1Y) 120.5% 7.9% -779.2%
Net income CAGR (3Y) -11.3% 6.2% -28.4%
EPS growth (1Y) 118.3% 9.7% -778.9%
EPS CAGR (3Y) -10.6% 7.6% -28.4%
Operating cash flow growth (1Y) 34.4% 21.9% -0.8%
Operating cash flow CAGR (3Y) 9.4% 4.5% 5.3%
Free cash flow growth (1Y) 37.6% 24.3% -3.0%
Free cash flow CAGR (3Y) 12.7% 5.1% 17.6%

Profitability

14 metrics
MetricTECHTMORGEN
Gross margin 65.8% 41.1% 53.5%
EBITDA margin 27.5% 24.4% 13.6%
Operating margin 19.6% 17.9% 2.3%
Pretax margin 18.5% 16.7% 1.0%
Net margin 14.0% 14.9% -1.5%
FCF margin 25.1% 16.0% 13.2%
Operating cash flow margin 27.5% 19.7% 16.1%
Return on equity 7.7% 13.2% -1.7%
Return on assets 6.3% 6.2% -1.2%
Return on invested capital 7.8% 8.0% 0.0%
Return on capital employed 10.7% 8.5% 0.6%
Asset turnover 0.5x 0.4x 0.3x
Cash conversion (OCF / net income) 2.0x 1.3x -11.0x
Stock comp / revenue 1.6% 0.7% 4.2%

Financial Health

11 metrics
MetricTECHTMORGEN
Debt / assets 7.6% 36.2% 19.0%
Debt / equity 0.1x 0.8x 0.3x
Net debt / EBITDA -0.4x 3.1x -2.8x
Debt / FCF 0.6x 5.4x 5.2x
Liabilities / assets 17.9% 52.1% 28.5%
Equity / assets 82.1% 47.9% 71.5%
Interest coverage 27.2x 12.0x 0.8x
Current ratio 2.3x 1.8x 9.9x
Quick ratio 1.5x 1.2x 8.1x
Cash ratio 1.0x 0.4x 6.9x
Altman Z-score 16.15 4.18 7.80

Shareholder Returns

7 metrics
MetricTECHTMORGEN
Dividend yield 0.5% 0.3% –
Net buyback yield -0.5% 1.6% -0.2%
Shareholder yield 0.1% 1.8% -0.2%
Payout ratio (earnings) 29.1% 9.5% –
Payout ratio (FCF) 16.2% 8.9% –
Dividend growth (1Y) -0.2% 8.0% –
Dividend CAGR (3Y) -0.2% 10.1% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusTECHTMORGEN
Forward P/E 33.4xFY2027 27.0xFY2026 86.0xFY2026
EPS, next fiscal year $2.18FY2027 $25.92FY2026 $1.95FY2026
EPS growth, next FY +13.0%FY2027 +13.3%FY2026 +14.0%FY2026
EPS growth, the year after +3.2% +2.2% +29.2%
Revenue, next fiscal year $1.19BFY2027 $50.12BFY2026 $791.31MFY2026
Revenue growth, next FY -2.1%FY2027 +12.5%FY2026 +7.2%FY2026
Revenue growth, the year after +13.5% -2.7% +44.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersTECHTMORGEN
Held by institutions 100.0% 90.2% 100.0%
Institutions holding 599 2,627 483
Change in shares held, QoQ -0.6% +0.8% +1.2%
Institutions buying 293 1,145 273
Institutions selling 241 1,145 141
Buyers to sellers 1.22 1.00 1.94

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

TECHTMORGEN
TECH 1.00 0.45 0.44
TMO 0.45 1.00 0.68
RGEN 0.44 0.68 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, TECH, TMO and RGEN?

Thermo Fisher Scientific (TMO) is the largest by market capitalisation: Bio-Techne (TECH) $11.43B, Thermo Fisher Scientific (TMO) $259.44B, Repligen (RGEN) $9.51B.

Which stock is cheaper, TECH, TMO and RGEN?

Thermo Fisher Scientific (TMO) trades on the lowest price-to-earnings ratio (Bio-Techne (TECH) 66.4x, Thermo Fisher Scientific (TMO) 36.6x, Repligen (RGEN) -804.0x). On next year's consensus earnings, Thermo Fisher Scientific (TMO) is cheapest (Bio-Techne (TECH) 33.4x, Thermo Fisher Scientific (TMO) 27.0x, Repligen (RGEN) 86.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Repligen (RGEN) grew revenue fastest over the trailing twelve months: Bio-Techne (TECH) +0.9%, Thermo Fisher Scientific (TMO) +8.3%, Repligen (RGEN) +13.8%.

Which company is more profitable?

Thermo Fisher Scientific (TMO) has the highest net margin (Bio-Techne (TECH) 14.0%, Thermo Fisher Scientific (TMO) 14.9%, Repligen (RGEN) -1.5%). On return on invested capital, Thermo Fisher Scientific (TMO) leads (Bio-Techne (TECH) 7.8%, Thermo Fisher Scientific (TMO) 8.0%, Repligen (RGEN) 0.0%).

Which stock has performed better?

Over the past year Thermo Fisher Scientific (TMO) returned the most: Bio-Techne (TECH) +19.8%, Thermo Fisher Scientific (TMO) +20.7%, Repligen (RGEN) +11.4%. Over five years, Thermo Fisher Scientific (TMO) compounded fastest (Bio-Techne (TECH) -10.4%/yr, Thermo Fisher Scientific (TMO) +2.0%/yr, Repligen (RGEN) -8.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Bio-Techne (TECH) has the highest dividend yield: Bio-Techne (TECH) 0.55%, Thermo Fisher Scientific (TMO) 0.26%. Repligen (RGEN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Thermo Fisher Scientific (TMO) has been the steadiest (Bio-Techne (TECH) 42.8%, Thermo Fisher Scientific (TMO) 30.7%, Repligen (RGEN) 46.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, TECH, TMO and RGEN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Thermo Fisher Scientific (TMO) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.